Specific reduction of insulin disulfides by macrophage migration inhibitory factor (MIF) with glutathione and dihydrolipoamide: potential role in cellular redox processes

被引:57
作者
Kleemann, R
Mischke, R
Kapurniotu, A
Brunner, H
Bernhagen, J [1 ]
机构
[1] Univ Stuttgart, Fraunhofer Inst FH IGB, Chair Interfacial Engn, Biochem Lab, D-70569 Stuttgart, Germany
[2] Univ Tubingen, Inst Physiol Chem, D-72076 Tubingen, Germany
来源
FEBS LETTERS | 1998年 / 430卷 / 03期
关键词
macrophage migration inhibitory factor; insulin disulfide reduction; redox process;
D O I
10.1016/S0014-5793(98)00654-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The molecular mechanism of action of MIF, a cytokine that plays a critical role in the host immune and inflammatory response, has not yet been identified. We recently demonstrated that MIF is an enzyme that exhibits oxidoreductase activity by a cysteine thiol-mediated mechanism. Here,ve further investigated this function by examining the reduction of insulin disulfides by wild-type human MIF (wtMIF) using various substrates, namely glutathione (GSH), dihydrolipoamide, cysteine, beta-mercaptoethanol and dithiothreitol. The activity of wtMIF was compared to that of the relevant cysteine mutants of MIF and to two carboxy-truncated mutants. Only GSH and dihydrolipoamide were found to serve as reductants, whereas the other substrates were not utilized by MIF. Reduction of insulin disulfides by MIF was closely dependent on the presence of the Cys(57)-Ala-Leu-Cys(60) (CALC) motif-forming cysteines C57 and C60, whereas C81 was not involved (activities: 51 +/- 13%, 14 +/- 5%, and 70 +/- 12% of wtMIF, respectively, and 20 +/- 3% for the double mutant C57S/C60S). Confirming the notion that the activity of MIF was dependent on the CALC motif in the central region of the MIF sequence, the C-terminal deletion mutants MIF(1-105) and MIF(1-110) were found to be fully active. The favored use of GSH and dihydrolipoamide indicated that MIF may be involved in the regulation of cellular redox processes and was supported further by the finding that,MIF expression by the cell lines COS-1 and RAW 264.7 was significantly induced upon treatment with the oxidant hydrogen peroxide. (C) 1998 Federation of European Biochemical Societies.
引用
收藏
页码:191 / 196
页数:6
相关论文
共 36 条
  • [1] Redox potentials of glutaredoxins and other thiol-disulfide oxidoreductases of the thioredoxin superfamily determined by direct protein-protein redox equilibria
    Åslund, F
    Berndt, KD
    Holmgren, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) : 30780 - 30786
  • [2] An essential regulatory role for macrophage migration inhibitory factor in T-cell activation
    Bacher, M
    Metz, CN
    Calandra, T
    Mayer, K
    Chesney, J
    Lohoff, M
    Gemsa, D
    Donnelly, T
    Bucala, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) : 7849 - 7854
  • [3] INTERPLAY BETWEEN LIPOIC ACID AND GLUTATHIONE IN THE PROTECTION AGAINST MICROSOMAL LIPID-PEROXIDATION
    BAST, A
    HAENEN, GRMM
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 963 (03) : 558 - 561
  • [4] Biochemical and nutational investigations of the enzymatic activity of macrophage migration inhibitory factor
    Bendrat, K
    AlAbed, Y
    Callaway, DJE
    Peng, T
    Calandra, T
    Metz, CN
    Bucala, R
    [J]. BIOCHEMISTRY, 1997, 36 (49) : 15356 - 15362
  • [5] MIF IS A PITUITARY-DERIVED CYTOKINE THAT POTENTIATES LETHAL ENDOTOXEMIA
    BERNHAGEN, J
    CALANDRA, T
    MITCHELL, RA
    MARTIN, SB
    TRACEY, KJ
    VOELTER, W
    MANOGUE, KR
    CERAMI, A
    BUCALA, R
    [J]. NATURE, 1993, 365 (6448) : 756 - 759
  • [6] PURIFICATION, BIOACTIVITY, AND SECONDARY STRUCTURE-ANALYSIS OF MOUSE AND HUMAN MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF)
    BERNHAGEN, J
    MITCHELL, RA
    CALANDRA, T
    VOELTER, W
    CERAMI, A
    BUCALA, R
    [J]. BIOCHEMISTRY, 1994, 33 (47) : 14144 - 14155
  • [7] An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction
    Bernhagen, J
    Bacher, M
    Calandra, T
    Metz, CN
    Doty, SB
    Donnelly, T
    Bucala, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) : 277 - 282
  • [8] MIF AS A GLUCOCORTICOID-INDUCED MODULATOR OF CYTOKINE PRODUCTION
    CALANDRA, T
    BERNHAGEN, J
    METZ, CN
    SPIEGEL, LA
    BACHER, M
    DONNELLY, T
    CERAMI, A
    BUCALA, R
    [J]. NATURE, 1995, 377 (6544) : 68 - 71
  • [9] CALANDRA T, 1994, J EXP MED, V179, P1985
  • [10] CALANDRA T, 1994, 6 C EUR SHOCK SOC ST